The mRNA (Messenger RNA) theme has 13 member stock(s) today, with an average return of -1.5%. The leading stock is 한미약품 (+2.2%, trading value 62,382,170,750).
A next-generation vaccine and therapeutic platform utilizing genetic information delivery within the body, attracting attention for its potential expansion beyond infectious diseases into oncology and intractable conditions.
| Stock | Price | Return | Trading Value |
|---|---|---|---|
| 한미약품 | 474,000 | +2.2% | 62,382,170,750 |
| 큐라티스 | 2,950 | +2.1% | 83,542,000 |
| 아미노로직스 | 1,072 | +0.6% | 78,184,025 |
| 이연제약 | 10,020 | -0.2% | 102,913,280 |
| 나이벡 | 14,320 | -0.7% | 386,789,815 |
| 서린바이오 | 4,020 | -0.9% | 25,353,323 |
| 한미사이언스 | 49,700 | -1.2% | 12,344,995,875 |
| 에스티팜 | 88,800 | -1.3% | 5,400,676,550 |
| 녹십자 | 126,600 | -1.3% | 1,925,362,350 |
| 인벤티지랩 | 24,950 | -1.4% | 1,491,692,625 |
| 파미셀 | 10,960 | -2.7% | 5,416,748,045 |
| 아이진 | 2,010 | -6.5% | 476,158,931 |
| 올릭스 | 100,100 | -8.4% | 36,170,927,400 |
This page's data is for reference only and is not investment advice. Actual market data may differ.